Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosing regimens associated with extended release paliperidone injectable formulations

Dosing regimens associated with extended release paliperidone injectable formulations

US Patent 11439647 · Granted Sep 13, 2022

Estimated economic value: $670,695,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dosing regimens associated with extended release paliperidone injectable formula2025
Dosing regimens associated with extended release paliperidone injectable formula2025
Dosing regimens associated with extended release paliperidone injectable formula2025
Dosing regimens associated with extended release paliperidone injectable formula2024
Dosing regimens associated with extended release paliperidone injectable formula2024
Dosing regimens associated with extended release paliperidone injectable formula2024
Dosing regimens associated with extended release paliperidone injectable formula2024
Methods for the treatment of depression2022
Methods for the treatment of depression2021
Methods for the treatment of depression2020